Log in to your Inderes Free account to see all free content on this page.
Magle Chemoswed Holding
4.20 SEK
-2.33 %
Less than 1K followers
MAGLE
First North Stockholm
Biotechnology & Pharmaceuticals
Health Care
Overview
Financials & Estimates
Ownership
Dividend
Investor consensus
Valuation
Income statement
Quarter data
Quarter data
Financial statements, revenue, EBIT, valuation metrics, and quarterly estimates for Magle Chemoswed Holding
| Q3/24 | Q4/24 | 2024 | Q1/25 | Q2/25 | Q3/25 | Q4/25 | 2025 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | 64.6 | 87.2 | 236.0 | 81.4 | 52.4 | 71.5 | 77.7 | 282.9 |
| EBITDA | -55.2 | 101.7 | 58.9 | 18.8 | -20.6 | 33.4 | -58.3 | -26.7 |
| EBIT | -67.9 | 85.6 | 23.2 | 2.1 | -29.0 | 20.3 | -120.3 | -127.0 |
| EBIT-% | -105.0 % | 98.1 % | 9.8 % | 2.6 % | -55.4 % | 28.3 % | -154.9 % | -44.9 % |
| Profit before taxes | 10.7 | -2.0 | 12.2 | -1.1 | -27.9 | 2.9 | -137.4 | -163.3 |
| Net income | 9.6 | -0.7 | 11.9 | -1.2 | -27.8 | 3.1 | -134.0 | -159.9 |
Login required
This content is only available for logged in users